Moderna Inc. stock: TD Cowen keeps USD 90.00 target pre-market
Published on 10/22/2026 at 08:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst stance and trading setup
- A TD Cowen report dated October 21, 2026, retained a Hold rating and a USD 90.00 target for Moderna.
- The home market context is the Nasdaq Composite in the United States in 2026.
- Moderna Inc. stock trades pre-market at EUR 217.48 at 8:09 a.m. CEST at Lang & Schwarz on October 22, 2026.
On October 21, 2026, Tyler Van Buren of TD Cowen maintained a Hold rating on Moderna and set a USD 90.00 price target, according to Markets Insider. Moderna Inc. stock trades pre-market at EUR 217.48 at 8:09 a.m. CEST at Lang & Schwarz on October 22, 2026.
Analyst view on Moderna
The report identified Van Buren as the TD Cowen analyst covering Moderna and described the rating as Hold. The item was published on October 21, 2026, and attributed the target and rating to the analyst's report through Markets Insider.
Ahead of the Xetra open
The bid was EUR 217.35 and the ask was EUR 217.60, a spread of less than 1.00 percent. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Moderna stock.
How Moderna makes money
Moderna develops mRNA medicines designed to prompt the body to create tools to treat or prevent disease, according to the company's website. The home market is the Nasdaq Composite in the United States. Market context: Market report Nasdaq Composite.
